Cellectis SA (CLLS)
1.87
+0.01
(+0.54%)
USD |
NASDAQ |
Nov 22, 16:00
1.88
+0.01
(+0.53%)
After-Hours: 20:00
Cellectis Revenue (Annual): 0.755M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.755M |
| December 31, 2022 | 19.17M |
| December 31, 2021 | 30.35M |
| December 31, 2020 | 51.06M |
| December 31, 2019 | 15.19M |
| December 31, 2018 | 12.73M |
| December 31, 2017 | 25.19M |
| December 31, 2016 | 44.81M |
| December 31, 2015 | 55.86M |
| Date | Value |
|---|---|
| December 31, 2014 | 26.30M |
| December 31, 2013 | 7.404M |
| December 31, 2012 | 14.95M |
| December 31, 2011 | 20.73M |
| December 31, 2010 | 20.84M |
| December 31, 2009 | 14.53M |
| December 31, 2008 | 14.77M |
| December 31, 2007 | 4.101M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.755M
Minimum
2023
51.06M
Maximum
2020
23.30M
Average
19.17M
Median
2022
Revenue (Annual) Benchmarks
| Edap TMS SA | 65.41M |
| Genfit SA | 30.92M |
| DBV Technologies SA | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | 0.4741M |